Dose–response of benazepril on biomarkers of the classical and alternative pathways of the renin–angiotensin–aldosterone system in dogs

Angiotensin-converting enzyme inhibitors (ACEI) such as benazepril are commonly prescribed in both humans and dogs with heart disease to mitigate the renin–angiotensin–aldosterone system (RAAS); however, the dose-dependent effects of benazepril on comprehensive RAAS components remain unknown. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sotillo, Samantha, Ward, Jessica L., Guillot, Emilie, Domenig, Oliver, Yuan, Lingnan, Smith, Joseph S., Gabriel, Vojtech, Iennarella-Servantez, Chelsea A., Mochel, Jonathan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932142/
https://www.ncbi.nlm.nih.gov/pubmed/36792677
http://dx.doi.org/10.1038/s41598-023-29771-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932142/
https://www.ncbi.nlm.nih.gov/pubmed/36792677
http://dx.doi.org/10.1038/s41598-023-29771-x

Ejemplares similares